Denna sida på svenska
Loading profile information...


Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
Lemoine L, Gillberg Pg, Svedberg M, Stepanov V, Jia Z, Huang J, et al
Alzheimer's research & therapy 2017;9(1):96-

Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography
Lemoine L, Saint-aubert L, Nennesmo I, Gillberg Pg, Nordberg A
Scientific reports 2017;7():45496-

Development of [11C]/[3H]THK-5351 - A potential novel carbon-11 tau imaging PET radioligand
Stepanov V, Svedberg M, Jia Z, Krasikova R, Lemoine L, Okamura N, et al
Nuclear medicine and biology 2017;46():50-53

Tau PET imaging: present and future directions
Saint-aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-vieitez E, Nordberg A
Molecular neurodegeneration 2017;12(1):19-

Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue
Lemoine L, Saint-aubert L, Marutle A, Antoni G, Eriksson Jp, Ghetti B, et al
Acta neuropathologica communications 2015;3():40-

A new single-photon emission computed tomography (SPECT) imaging agent for serotonin transporters: [(125)I]Flip-IDAM, (2-((2-((dimethylamino)methyl)-4-iodophenyl)thio)phenyl)methanol
Zheng P, Lieberman Bp, Ploessl K, Lemoine L, Miller S, Kung Hf
Bioorganic & medicinal chemistry letters 2013;23(3):869-72

Characterization of FlipIDAM as a SERT-selective SPECT imaging agent
Lemoine L, Lieberman Bp, Ploessl K, Zheng Pg, Kung Hf

MPTP animal model of Parkinsonism: dopamine cell death or only tyrosine hydroxylase impairment? A study using PET imaging, autoradiography, and immunohistochemistry in the cat
Aznavour N, Cendres-bozzi C, Lemoine L, Buda C, Sastre Jp, Mincheva Z, et al
CNS neuroscience & therapeutics 2012;18(11):934-41

Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging
Lemoine L, Becker G, Vacher B, Billard T, Lancelot S, Newman-tancredi A, et al
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(6):969-76

Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer
Lemoine L, Andries J, Le Bars D, Billard T, Zimmer L
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(11):1811-8

Synthesis and biological evaluation of potential 5-HT(7) receptor PET radiotracers
Andries J, Lemoine L, Le Bars D, Zimmer L, Billard T
European journal of medicinal chemistry 2011;46(8):3455-61

[18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging
Lemoine L, Verdurand M, Vacher B, Blanc E, Le Bars D, Newman-tancredi A, et al
European journal of nuclear medicine and molecular imaging 2010;37(3):594-605

Looking for a 5-HT7 radiotracer for positron emission tomography
Andries J, Lemoine L, Mouchel-blaisot A, Tang S, Verdurand M, Le Bars D, et al

Functional correlates for 5-HT(1A) receptors in maternally deprived rats displaying anxiety and depression-like behaviors
Lambás-señas L, Mnie-filali O, Certin V, Faure C, Lemoine L, Zimmer L, et al
Progress in neuro-psychopharmacology & biological psychiatry 2009;33(2):262-8

Synthesis and biological evaluation in rat and cat of [18F]12ST05 as a potential 5-HT6 PET radioligand
Tang S, Verdurand M, Joseph B, Lemoine L, Daoust A, Billard T, et al
Nuclear medicine and biology 2007;34(8):995-1002

Show all publications